Ipsen Advisor Group’s Clorox CLX Stock Holding History

Ipsen Advisor Group’s Portfolio CLX Stock Details CLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$486K	Buy	4,693 +635	+16%	+$72K	0.34%	75
2025 Q4	$409K	Buy	+4,058	New	+$441K	0.29%	81

Other funds holding CLX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Ipsen Advisor Group's CLX Position: Q1 2026 in Review

Ipsen Advisor Group increased its Clorox (CLX) stake by 16% in Q1 2026, buying an estimated $72K and bringing the position to 4,693 shares worth $486K. The position accounts for 0.34% of the portfolio, ranked #75.

Ipsen Advisor Group first reported a position in CLX in Q4 2025 and has held it in 2 quarters since. 1,080 funds tracked by Wall St. Rank hold CLX as of Q1 2026.

Ipsen Advisor Group held 4,693 shares of Clorox worth $486K as of Q1 2026.
Ipsen Advisor Group bought 635 Clorox shares in Q1 2026, an estimated $72K.
Clorox made up 0.34% of Ipsen Advisor Group's portfolio in Q1 2026, its #75 holding.
Ipsen Advisor Group first reported a position in Clorox in Q4 2025 and has held it in 2 quarters since.
1,080 funds tracked by Wall St. Rank held Clorox as of Q1 2026.

Based on Ipsen Advisor Group's 13F filing for Q1 2026, filed 29 May 2026.